Tumorigenic stem and progenitor cells: Implications for the therapeutic index of anti-cancer agents
- 13 May 2007
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 122 (3), 385-391
- https://doi.org/10.1016/j.jconrel.2007.05.005
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Identification of Pancreatic Cancer Stem CellsCancer Research, 2007
- Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessProceedings of the National Academy of Sciences, 2006
- Stem Cells and Their NichesScience, 2006
- Small Intestinal Organoid-Derived SP Cells Contribute to Repair of Irradiation-Induced Skin InjuryStem Cells and Development, 2005
- Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defenseToxicology and Applied Pharmacology, 2004
- Molecular phenotype of airway side population cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Identification rare event detection and analysis of dendritic cell subsets in broncho alveolar lavage fluid and peripheral blood by flow cytometryFrontiers in Bioscience-Landmark, 2003
- Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.The Journal of Experimental Medicine, 1996
- Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cellsCell, 1991